Successful treatment of enterocutaneous fistula in a premature newborn by using octreotide.
A premature newborn with an enterocutaneous fistula after repair of duodenal perforation is reported to emphasize the therapeutic effect of octreotide in persistent fistula even in a very small infant. Our report showed that use of octreotide was safe even in premature infants with intestinal fistula. Close monitorization of biochemical and blood parameters is needed in patients treated with octreotide.
Büyükyavuz
Ilker
I
Department of Pediatric Surgery, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Karnak
Ibrahim
I
Yiğit
Sule
S
Tanyel
F Cahit
FC
D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D007412:Intestinal Fistula / Q000188:drug therapy*; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D015282:Octreotide